Cargando…

Transcriptome-Guided Drug Repurposing for Aggressive SCCs

Despite a significant rise in the incidence of cutaneous squamous cell carcinoma (SCC) in recent years, most SCCs are well treatable. However, against the background of pre-existing risk factors such as immunosuppression upon organ transplantation, or conditions such as recessive dystrophic epidermo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zauner, Roland, Wimmer, Monika, Dorfer, Sonja, Ablinger, Michael, Koller, Ulrich, Piñón Hofbauer, Josefina, Guttmann-Gruber, Christina, Bauer, Johann W., Wally, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780441/ https://www.ncbi.nlm.nih.gov/pubmed/35055192 http://dx.doi.org/10.3390/ijms23021007

Ejemplares similares

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC
por: Zauner, Roland, et al.
Publicado: (2023)

A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
por: Wimmer, Monika, et al.
Publicado: (2020)

5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022)

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents
por: Liemberger, Bernadette, et al.
Publicado: (2023)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
por: Ablinger, Michael, et al.
Publicado: (2018)

Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis
por: Brunner, Susanne M., et al.
Publicado: (2023)

Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
por: Kocher, Thomas, et al.
Publicado: (2017)

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023)

Applying RCS and SCCS
por: Bolinger, Don, et al.
Publicado: (1995)

International Conference on SCCS 2008
por: Collective
Publicado: (2008)

RNA Trans-Splicing Modulation via Antisense Molecule Interference
por: Liemberger, Bernadette, et al.
Publicado: (2018)

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
por: Petković, Igor, et al.
Publicado: (2022)

Can we be SMaRT-er in our approach to cancer therapy?
por: Gruber, Christina, et al.
Publicado: (2015)

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
por: Ablinger, Michael, et al.
Publicado: (2021)

Epigenetic and metabolic regulation of epidermal homeostasis
por: Wagner, Roland N., et al.
Publicado: (2021)

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
por: Woess, Katharina, et al.
Publicado: (2022)

Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)

Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders
por: Koller, Ulrich, et al.
Publicado: (2014)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development
por: Di Filippo, Michela, et al.
Publicado: (2022)

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
por: Bischof, Johannes, et al.
Publicado: (2022)

Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
por: Leb-Reichl, Victoria M, et al.
Publicado: (2021)

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
por: Roelens, Maroussia, et al.
Publicado: (2020)

Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma
por: Chen, Kathryn, et al.
Publicado: (2022)

Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination
por: Kocher, Thomas, et al.
Publicado: (2019)

The level of spiritual care competence of Polish nurses and the psychometric properties of the spiritual care competence scale (SCCS)
por: Machul, Michał, et al.
Publicado: (2022)

Trans-Splicing Improvement by the Combined Application of Antisense Strategies
por: Koller, Ulrich, et al.
Publicado: (2015)

Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
por: Guttmann-Gruber, Christina, et al.
Publicado: (2021)

A novel screening system improves genetic correction by internal exon replacement
por: Koller, Ulrich, et al.
Publicado: (2011)

Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis
por: Arumugam, Aadithya, et al.
Publicado: (2013)

Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
por: Prodinger, Christine, et al.
Publicado: (2020)

Feline SCCs of the Head and Neck Display Partial Epithelial-Mesenchymal Transition and Harbor Stem Cell-like Cancer Cells
por: Kummer, Stefan, et al.
Publicado: (2023)

Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes
por: Guttmann-Gruber, Christina, et al.
Publicado: (2018)

MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
por: Boxhammer, Elke, et al.
Publicado: (2023)

Intracranially protruded bilateral posterior and superior SCCs with multiple dehiscences in a patient with positional vertigo: CT and MR imaging findings and review of literature
por: Kundaragi, Nischal G, et al.
Publicado: (2014)

MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex
por: Lettner, Thomas, et al.
Publicado: (2013)

An ex vivo RNA trans‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex
por: Peking, P., et al.
Publicado: (2018)

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model
por: Kocher, T, et al.
Publicado: (2016)

Gene Replacement Therapies for Genodermatoses: A Status Quo
por: Koller, Ulrich, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r2h2grvir43vrubspr7f62cp7e